UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition ISOsandoz-10mg-Capsule-SE-IS-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100000848-00058873, http://ema.europa.eu/fhir/eurdId
/10488
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Capsule, soft
indication:
Svåra former av akne (till exempel nodulär eller konglobat akne eller akne med risk för permanent ärrbildning) som inte kontrolleras med adekvat standardbehandling med systemiska antibakteriella läkemedel och lokalbehandling.
legalStatusOfSupply: Medicinal product subject to medical prescription
additionalMonitoringIndicator: The medicinal product is included or removed from the list of medicinal products that are subject to additional monitoring (as applicable).
classification: D10BA01
name
productName: Isotretinoin Sandoz 10 mg Kapsel, mjuk
part
part: Isotretinoin Sandoz
type: Invented name part
part
part: 10 mg
type: Strength part
part
part: Kapsel, mjuk
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish